Hyperglycemia-induced insulin resistance is not caused by overactivity of the hexosamine pathway in type 2 diabetes

被引:0
|
作者
Span, P
Pouwels, M
Tack, C
Olthaar, A
Sweep, F
Huvers, F
Von Engelen, B
Lutterman, J
Hermus, A
机构
[1] Catholic Univ Nijmegen, Dept Chem Endocrinol, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[2] Catholic Univ Nijmegen, Div Gen Internal Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[3] Catholic Univ Nijmegen, Dept Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[4] Catholic Univ Nijmegen, Dept Neurol, Med Ctr, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
674
引用
收藏
页码:A176 / A176
页数:1
相关论文
共 50 条
  • [1] Euglycemia improves hyperglycemia-induced insulin resistance in patients with uncontrolled type 2 diabetes
    Pouwels, M
    Tack, C
    Hermus, A
    Lutterman, J
    [J]. DIABETOLOGIA, 2001, 44 : A190 - A190
  • [2] Detoxification of Hyperglycemia-induced Glucose Toxicity by the Hexosamine Biosynthetic Pathway
    Wang, Andrew Jun
    Wang, Aimin
    Hascall, Vincent
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (02):
  • [3] Examining the hexosamine biosynthesis pathway in hyperglycemia-induced accelerated atherosclerosis
    Dang, V. I. T.
    Petlura, C.
    Beriault, D. R.
    Shi, Y.
    Werstuck, G. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 95 - 95
  • [4] Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
    Jiang, Bo
    Zhang, Xiaoying
    Di, Dongmei
    Luo, Guanghua
    Shi, Yuanping
    Zhang, Jun
    Berggren-Soderlund, Maria
    Nilsson-Ehle, Peter
    Xu, Ning
    [J]. LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [5] Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
    Bo Jiang
    Xiaoying Zhang
    Dongmei Di
    Guanghua Luo
    Yuanping Shi
    Jun Zhang
    Maria Berggren-Söderlund
    Peter Nilsson-Ehle
    Ning Xu
    [J]. Lipids in Health and Disease, 14
  • [6] Effects of troglitazone on hyperglycemia-induced insulin resistance
    Lee, MK
    Kim, KA
    Kim, YS
    Ahn, KJ
    Chung, JH
    Min, YK
    Lee, MS
    Kim, KW
    Miles, PG
    Olefsky, JM
    [J]. RECENT ADVANCES ON THE PATHOGENESIS AND MANAGEMENT OF DIABETES MELLITUS: PROCEEDINGS OF THE 9TH KOREA-JAPAN SYMPOSIUM ON DIABETES MELLITUS, KYONGJU, KOREA, 11-12 APRIL 1997, 1998, 1149 : 285 - 288
  • [7] Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes
    Pouwels, MJJ
    Span, PN
    Tack, CJ
    Olthaar, AJ
    Sweep, CGJF
    Engelen, BGVN
    De Jong, JG
    Lutterman, JA
    Hermus, AR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 5179 - 5184
  • [8] Hyperglycemia-induced alterations of the vascular endothelium in type 2 diabetes mellitus
    Hoffmann, Brian
    Prisco, Anthony
    Widlansky, Michael
    Greene, Andrew
    [J]. FASEB JOURNAL, 2015, 29
  • [9] Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance
    Miles, PDG
    Higo, K
    Romeo, OM
    Lee, MK
    Rafaat, K
    Olefsky, JM
    [J]. DIABETES, 1998, 47 (03) : 395 - 400
  • [10] Troglitazone prevents hyperglycemia-induced insulin resistance in rats.
    Miles, PD
    Lee, MK
    Romeo, O
    Rafaat, K
    Moossa, AR
    [J]. DIABETES, 1996, 45 : 807 - 807